🏛️ Verified NIH Record • Updated 2026-07-22
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (NCT07035093)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Eli Lilly and Company
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
Who can join: Review the eligibility criteria below.
Location: MD First Research - Chandler — Chandler, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (40 Sites)
Showing the first 25 of 40 sites.
- MD First Research - Chandler — Chandler, Arizona
- Tucson Orthopaedic Institute - North Wyatt Drive — Tucson, Arizona
- Ark Clinical Research - Fountain Valley — Fountain Valley, California
- St Joseph Heritage Healthcare — Fullerton, California
- Clinical Research Institute — Los Angeles, California
- Artemis Institute for Clinical Research — San Diego, California
- Alpine Clinical Research Center — Boulder, Colorado
- K2 Medical Research - Daytona Beach — Daytona Beach, Florida
- Flourish Research - Miami, LLC — Miami, Florida
- IMA Clinical Research St. Petersburg — St. Petersburg, Florida
- Care Access - Tampa — Tampa, Florida
- Charter Research - Lady Lake — The Villages, Florida
- Conquest Research — Winter Park, Florida
- Cotton O'Neil Clinical Research Center — Topeka, Kansas
- Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana
- MedVadis Research Corporation — Waltham, Massachusetts
- Great Lakes Research Group, Inc. — Bay City, Michigan
- Clinvest Headlands Llc — Springfield, Missouri
- Center for Clinical Research — Winston-Salem, North Carolina
- Altoona Center For Clinical Research — Duncansville, Pennsylvania
- New Phase Research and Development — Knoxville, Tennessee
- FutureSearch Trials of Neurology — Austin, Texas
- Mercy Family Clinic — Dallas, Texas
- Houston Research Institute — Houston, Texas
- Sovah Clinical Research-River District — Danville, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.